CABR NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Caring Brands, Inc. Common Stock · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data Download investor PDF
Latest close 1.45 USD
11.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 34.9% above the Trend Line and sits at 19.0% of its 52-week range. The latest completed week returned 11.5%, after a 19.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 44/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.

Setup score 46 out of 100
Latest Close 1.45 USD 24 Jul 2026
1W Return 11.5% latest completed week
4W Return 19.8% short-term follow-through
12W Return 36.8% quarterly tape
Trend Breadth 21.6% 8 of 37 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 5 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 11.5% Latest completed week; four-week move 19.8%. Indicator stack 40/70 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 44/100 36 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 34.9% above the Trend Line and sits at 19.0% of its 52-week range. The latest completed week returned 11.5%, after a 19.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6712-week average 0.45

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.67Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers

No recent accumulation markers. 5 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 19.8% over four weeks, 36.8% over 12 weeks, and - over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W11.5%
4W19.8%
12W36.8%
26W49.8%
52W-
Active trend streak8 weeks
Active weeks in one year8
Trend breadth21.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.90Latest activity-pressure read.
Pressure change42.6%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength68/100Blend of value, momentum, and quality. Underlying universe rank 33; rank 1 is best.
Value58/100Relative valuation strength. Underlying universe rank 43; rank 1 is best.
Quality57/100Profitability and accounting quality. Underlying universe rank 44; rank 1 is best.
Momentum59/100Medium-term price momentum. Underlying universe rank 42; rank 1 is best.
Growth59/100Revenue and earnings growth. Underlying universe rank 42; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
4798.9x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-17.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
56.5%
Gross profit retained from each unit of revenue.
Operating margin
-166491.3%
Operating profit retained from revenue.
Free-cash-flow margin
-72853.2%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-24.6%
Net share repurchases relative to market value.
Shareholder yield
-24.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment44/100

Weighted news tone is neutral across 36 relevant articles.

5 positive · 21 neutral · 10 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-68.5%Distance below the 52-week high.
13-week volatility10.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2610 weeks finished lower.
Best week+23.5%Week of 20 Mar.
Worst week-19.2%Week of 8 May.
Latest week+11.5%Week of 24 Jul.

Shape of recent returns

Strong gains10
Modest gains4
Flat weeks2
Modest losses3
Sharp losses7
Recent vol10.8%13-week weekly-return volatility.
Base vol12.4%52-week weekly-return volatility.
Up/down split19/15Count of positive and negative weeks in the 52-week window.
Average skew11.3% / -10.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape40/100

Trend, activity pressure, participation, and risk combine to a 40/100 tape read.

 Indicator analysis45/100

Latest 12-week confirmation: trend 8/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.67; 5 reversal markers Factors60/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 92 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment44/100

Weighted news tone is neutral across 36 relevant articles.

Caring Brands (CABR) interim CFO reports 150,000-share issuer redemption at $1.00 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings13d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20261.45 USD11.5%1.07 USD1.07 USD0.90-263.0KOn
17 Jul 20261.30 USD-3.0%1.05 USD1.06 USD0.81-370.2KOn
10 Jul 20261.34 USD-0.7%1.04 USD1.05 USD0.77-317.9KOn
3 Jul 20261.35 USD11.6%1.04 USD1.04 USD0.65-366.0KOn
26 Jun 20261.21 USD0.8%1.03 USD1.03 USD0.63-202.1KOn
19 Jun 20261.20 USD6.2%1.03 USD1.03 USD0.60-492.1KOn
12 Jun 20261.13 USD-10.3%1.02 USD1.02 USD0.56-437.2KOn
5 Jun 20261.26 USD13.5%1.02 USD1.02 USD0.46-440.8KOn
29 May 20261.11 USD-3.5%-1.01 USD0.29-271.3KOff
22 May 20261.15 USD22.3%-1.00 USD--647.5KOff
15 May 20260.94 USD9.8%-1.00 USD--737.9KOff
8 May 20260.86 USD-19.2%-1.00 USD--235.7KOff
1 May 20261.06 USD-5.4%-1.01 USD--255.3KOff
24 Apr 20261.12 USD-7.4%-1.00 USD--308.2KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.